HeraMED Limited
HeraMED Limited
Your view on HMD.AX
Overview
What the company does, where it operates, and who runs it.
About HeraMED Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Anoushka Gungadin
- Headquarters
- 117 Camberwell Road, Hawthorn East, VIC, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Anoushka Gungadin
- Headquarters
- 117 Camberwell Road, Hawthorn East, VIC, AU
HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel.
Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management.
The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis.
A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for HeraMED Limited. Starting points for HeraMED Limited: beta 0.05 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for HeraMED Limited. HeraMED Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for HeraMED Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for HeraMED Limited. HeraMED Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AT1.AXAtomo Diagnostics Limited | Healthcare | Medical - Devices | — | ||
| BDX.AXBCAL Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| ENL.AXEnlitic, Inc. | Healthcare | Medical - Healthcare Information Services | — | ||
| EYE.AXNova Eye Medical Limited | Healthcare | Medical - Devices | — | ||
| IDT.AXIDT Australia Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IMC.AXImmuron Limited | Healthcare | Biotechnology | — | ||
| NOX.AXNoxopharm Limited | Healthcare | Biotechnology | — | ||
| NTI.AXNeurotech International Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| EKDHFEKF Diagnostics Holdings plc | Healthcare | OTC | $146.8M | ||
| ELEAFEL.En. S.p.A. | Healthcare | OTC | $1.3B | ||
| ELMDElectromed, Inc. | Healthcare | AMEX | $191.3M | ||
| ELXMFNova Eye Medical Limited | Healthcare | OTC | $541,183 | ||
| EMEDElectromedical Technologies, Inc. | Healthcare | OTC | $85,504 | ||
| EMV.AXEMVision Medical Devices Ltd | Healthcare | ASX | — | ||
| ENCWEnchanted World Inc. | Healthcare | OTC | $111 | ||
| ENOVEnovis Corporation | Healthcare | NYSE | $1.6B | ||
| ESMCEscalon Medical Corp. | Healthcare | OTC | $1.9M | ||
| ESTAEstablishment Labs Holdings Inc. | Healthcare | NASDAQ | $2.1B | ||
| EVARFLombard Medical, Inc. | Healthcare | OTC | $2,795 | ||
| EWEdwards Lifesciences Corporation | Healthcare | NYSE | $60.5B | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for HeraMED Limited. Coverage tracks HeraMED Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of HeraMED Limited.